Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action - PubMed (original) (raw)

. 2002 Sep 5;21(39):6071-81.

doi: 10.1038/sj.onc.1205731.

Affiliations

• PMID: 12203119
• DOI: 10.1038/sj.onc.1205731

Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action

Chris Tselepis et al. Oncogene. 2002.

Abstract

Barrett's metaplasia (BM) is an early lesion in the progression from oesophageal inflammation through dysplasia to the development of Barrett's adenocarcinoma (BA). Previous work indicates that BM and BA are associated with reduced E-cadherin expression and increased cytoplasmic/nuclear pools of its associated protein beta-catenin. beta-catenin participates in Wnt signalling and activates oncogene transcription by complexing with T-cells factors (TCF). One such oncogene is c-myc. We have previously shown that TNF-alpha can down-regulate E-cadherin expression. Here, we assess TNF-alpha expression in Barrett's metaplasia and examine if TNF-alpha can promote beta-catenin mediated transcription of oncogenes in a gastrointestinal model system. Employing immunohistochemistry and Western blot analysis of oesophageal tissue, epithelial expression of TNF-alpha increases with progression along the metaplasia-dysplasia-carcinoma sequence (P<0.001). beta-catenin mediated transcription was then assessed in TNF-alpha stimulated cell lines using the TOPFLASH reporter system whilst c-myc expression was assessed by real time PCR. In a columnar intestinal cell model, TNF-alpha induces c-myc expression which is induced via beta-catenin mediated transcription (P<0.05). This beta-catenin mediated transcription is independent of NF-kappaB activation. Thus, TNF-alpha is up-regulated in the progression of Barrett's oesophagus and beta-catenin mediated transcription of c-myc is a novel pathway whereby elevated levels of TNF-alpha may lead to oncogene transcription and altered biology in gastrointestinal epithelia and metaplasia.

PubMed Disclaimer

Similar articles

• Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
  Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J, Beauchamp D. Washington K, et al. Mod Pathol. 1998 Sep;11(9):805-13. Mod Pathol. 1998. PMID: 9758359
• Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation.
  Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. Bailey T, et al. Am J Pathol. 1998 Jan;152(1):135-44. Am J Pathol. 1998. PMID: 9422531 Free PMC article.
• Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
  O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV. O'Riordan JM, et al. Am J Gastroenterol. 2005 Jun;100(6):1257-64. doi: 10.1111/j.1572-0241.2005.41338.x. Am J Gastroenterol. 2005. PMID: 15929754
• Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
  Jankowski JA, Anderson M. Jankowski JA, et al. Aliment Pharmacol Ther. 2004 Oct;20 Suppl 5:71-80; discussion 95-6. doi: 10.1111/j.1365-2036.2004.02143.x. Aliment Pharmacol Ther. 2004. PMID: 15456468 Review.
• [Expression of transcription factor in Barrett's esophagus].
  Mutoh H. Mutoh H. Nihon Rinsho. 2005 Aug;63(8):1367-71. Nihon Rinsho. 2005. PMID: 16101223 Review. Japanese.

Cited by

• Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma.
  Elliott JA, Reynolds JV. Elliott JA, et al. Front Oncol. 2021 Mar 12;11:627270. doi: 10.3389/fonc.2021.627270. eCollection 2021. Front Oncol. 2021. PMID: 33777773 Free PMC article. Review.
• The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer.
  Fucci A, Colangelo T, Votino C, Pancione M, Sabatino L, Colantuoni V. Fucci A, et al. PPAR Res. 2012;2012:242498. doi: 10.1155/2012/242498. Epub 2012 Sep 6. PPAR Res. 2012. PMID: 22991505 Free PMC article.
• Barrett's Esophagus: Emerging Knowledge and Management Strategies.
  Bhardwaj A, McGarrity TJ, Stairs DB, Mani H. Bhardwaj A, et al. Patholog Res Int. 2012;2012:814146. doi: 10.1155/2012/814146. Epub 2012 May 30. Patholog Res Int. 2012. PMID: 22701199 Free PMC article.
• The tumor microenvironment in esophageal cancer.
  Lin EW, Karakasheva TA, Hicks PD, Bass AJ, Rustgi AK. Lin EW, et al. Oncogene. 2016 Oct 13;35(41):5337-5349. doi: 10.1038/onc.2016.34. Epub 2016 Feb 29. Oncogene. 2016. PMID: 26923327 Free PMC article. Review.
• A Novel Small Peptide Inhibitor of NF_κ_B, RH10, Blocks Oxidative Stress-Dependent Phenotypes in Cancer.
  Gambardella J, Ciccarelli M, Del Giudice C, Fiordelisi A, De Rosa M, Sala M, Pacelli R, Campiglia P, Trimarco B, Iaccarino G, Sorriento D. Gambardella J, et al. Oxid Med Cell Longev. 2018 Nov 4;2018:5801807. doi: 10.1155/2018/5801807. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30524659 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal